跳至主要内容
临床试验/NCT00540826
NCT00540826已完成不适用

Treatment Adherence and Compliance in Children and Adolescents on ADHD Medication and Emotional Expression in Clinical Practice

Eli Lilly and Company1 个研究点 分布在 1 个国家目标入组 518 人开始时间: 2007年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
518
试验地点
1

研究概览

简要总结

The primary research objective of this observational study is to evaluate treatment compliance over one year in children and adolescents who are newly initiated on medication approved for the treatment of ADHD in a routine clinical setting. Compliance will be assessed using the Pediatric Compliance Self-Rating (PCSR) Instrument. A patient will be considered as compliant at a given visit, if the PCSR score is at least 5, corresponding to taking the medication at least often.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 6-17 years old
  • diagnosis of ADHD according to ICD-10 or DSM-IV criteria
  • new initiation onto an approved medication to treat ADHD

排除标准

  • no specific exclusion criteria

研究组 & 干预措施

A

A: ADHD-patients receiving non-stimulants (e.g. atomoxetine)

干预措施: Atomoxetine (Drug)

B

B: ADHD-patients receiving stimulants

干预措施: stimulants (any approved ADHD medication) (Drug)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验